Global Full-Service Clinical Research Organization (CRO) Market Growth (Status and Outlook) 2025-2031
The global Full-Service Clinical Research Organization (CRO) market size is predicted to grow from US$ 19630 million in 2025 to US$ 36300 million in 2031; it is expected to grow at a CAGR of 10.8% from 2025 to 2031.
Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.
Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.
LPI (LP Information)' newest research report, the “Full-Service Clinical Research Organization (CRO) Industry Forecast” looks at past sales and reviews total world Full-Service Clinical Research Organization (CRO) sales in 2024, providing a comprehensive analysis by region and market sector of projected Full-Service Clinical Research Organization (CRO) sales for 2025 through 2031. With Full-Service Clinical Research Organization (CRO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Full-Service Clinical Research Organization (CRO) industry.
This Insight Report provides a comprehensive analysis of the global Full-Service Clinical Research Organization (CRO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Full-Service Clinical Research Organization (CRO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Full-Service Clinical Research Organization (CRO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Full-Service Clinical Research Organization (CRO) and breaks down the forecast by Type, by End Use, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Full-Service Clinical Research Organization (CRO).
This report presents a comprehensive overview, market shares, and growth opportunities of Full-Service Clinical Research Organization (CRO) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical CRO
Preclinical CRO
Segmentation by End Use:
Small Medium Enterprise
Large Enterprise
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Please note: The report will take approximately 2 business days to prepare and deliver.